Literature DB >> 26464616

Roles of Foxp3 in the occurrence and development of cervical cancer.

Qingshuang Luo1, Shulan Zhang1, Heng Wei1, Xiaoao Pang1, Huijie Zhang1.   

Abstract

OBJECTIVE: This study aimed to evaluate the relationship between forkhead box P3 (Foxp3) expression and clinicopathological characteristics of cervical cancer and to explore the influence of Foxp3 on the biological behaviors of cervical cancer cells.
METHODS: In this study, immunohistochemistry, lentivirus mediated transfection, Transwell assay; CCK-8 assay, real-time PCR and flow cytometry were employed to confirm the roles of Foxp3 in the occurrence and development of cervical cancer.
RESULTS: Foxp3 and p16(INK4a) were highly expressed in the cervical cancer and their expressions were related to the FIGO stage, tumor size, lymph node metastasis and serum SCC. Foxp3 had a high expression in the cervical cancer cells, tumor interstitium and metastatic lymph nodes. Foxp3 expression was positively related to p16(INK4a) expression in the cervical cancer. Foxp3 expression in the cervical cancer was negatively related to the prognosis: high Foxp3 expression predicted a poor prognosis. Silencing of Foxp3 was able to inhibit the proliferation and invasiveness of cervical cancer cells, promote their apoptosis, and induce the change in cell cycle. Silencing of Foxp3 also reduced the mRNA and protein expressions of p16(INK4a) in cervical cancer cells.
CONCLUSION: Foxp3 is highly expressed in the cervical cancer, and able to facilitate the proliferation and invasiveness of cervical cancer, change cell cycle and inhibit their apoptosis, resulting in the occurrence, development and metastasis of cervical cancer.

Entities:  

Keywords:  Cervical cancer; Foxp3; cell apoptosis; human papillomavirus; p16INK4a; regulatory T cells

Mesh:

Substances:

Year:  2015        PMID: 26464616      PMCID: PMC4583848     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  23 in total

Review 1.  Foxp3: a critical regulator of the development and function of regulatory T cells.

Authors:  Shohei Hori; Shimon Sakaguchi
Journal:  Microbes Infect       Date:  2004-07       Impact factor: 2.700

Review 2.  Chapter 2: The burden of HPV-related cancers.

Authors:  D Maxwell Parkin; Freddie Bray
Journal:  Vaccine       Date:  2006-08-31       Impact factor: 3.641

Review 3.  Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self.

Authors:  Shimon Sakaguchi
Journal:  Nat Immunol       Date:  2005-04       Impact factor: 25.606

4.  Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.

Authors:  Junliang Fu; Dongping Xu; Zhenwen Liu; Ming Shi; Ping Zhao; Baoyun Fu; Zheng Zhang; Huiyin Yang; Hui Zhang; Chunbao Zhou; Jinxia Yao; Lei Jin; Huifen Wang; Yongping Yang; Yang-Xing Fu; Fu-Sheng Wang
Journal:  Gastroenterology       Date:  2007-04-14       Impact factor: 22.682

5.  Usefulness of p16/Ki67 immunostaining in the triage of women referred to colposcopy.

Authors:  Jaume Ordi; Amaia Sagasta; Meritxell Munmany; Leonardo Rodríguez-Carunchio; Aureli Torné; Marta del Pino
Journal:  Cancer Cytopathol       Date:  2014-03       Impact factor: 5.284

6.  Association between quantitative high-risk human papillomavirus DNA load and cervical intraepithelial neoplasm risk.

Authors:  Hsiu-Ting Tsai; Ching-Hu Wu; Hsiao-Ling Lai; Ruei-Nian Li; Yi-Ching Tung; Hung-Yi Chuang; Trong-Neng Wu; Li-Jen Lin; Chi-Kung Ho; Hon-Wein Liu; Ming-Tsang Wu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-11       Impact factor: 4.254

7.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

8.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.

Authors:  Tyler J Curiel; George Coukos; Linhua Zou; Xavier Alvarez; Pui Cheng; Peter Mottram; Melina Evdemon-Hogan; Jose R Conejo-Garcia; Lin Zhang; Matthew Burow; Yun Zhu; Shuang Wei; Ilona Kryczek; Ben Daniel; Alan Gordon; Leann Myers; Andrew Lackner; Mary L Disis; Keith L Knutson; Lieping Chen; Weiping Zou
Journal:  Nat Med       Date:  2004-08-22       Impact factor: 53.440

Review 9.  Prognostic significance of overexpressed p16INK4a in patients with cervical cancer: a meta-analysis.

Authors:  Jiaying Lin; Andreas E Albers; Jinbao Qin; Andreas M Kaufmann
Journal:  PLoS One       Date:  2014-09-04       Impact factor: 3.240

10.  High FoxP3 expression in tumour cells predicts better survival in gastric cancer and its role in tumour microenvironment.

Authors:  G-F Ma; Q Miao; Y-M Liu; H Gao; J-J Lian; Y-N Wang; X-Q Zeng; T-C Luo; L-L Ma; Z-B Shen; Y-H Sun; S-Y Chen
Journal:  Br J Cancer       Date:  2014-02-18       Impact factor: 7.640

View more
  22 in total

1.  Overexpression of glucocorticoid receptor promotes the poor progression and induces cisplatin resistance through p38 MAP kinase in cervical cancer patients.

Authors:  Gwan Hee Han; Hee Yun; Julie Kim; Joon-Yong Chung; Jae-Hoon Kim; Hanbyoul Cho
Journal:  Am J Cancer Res       Date:  2022-07-15       Impact factor: 5.942

Review 2.  The potential applications of T cell receptor (TCR)-like antibody in cervical cancer immunotherapy.

Authors:  Sylvia Annabel Dass; Rehasri Selva Rajan; Gee Jun Tye; Venugopal Balakrishnan
Journal:  Hum Vaccin Immunother       Date:  2021-05-14       Impact factor: 3.452

3.  Overexpression of dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-related protein in cervical cancer and correlation with squamous cell carcinoma antigen.

Authors:  Xiangdong Wang; Yangmei Jiang; Menglang Yuan; Chunlin Chen; Keyong Wang; Qianshi Zhang; Yunfei Zuo; Shuangyi Ren
Journal:  Oncol Lett       Date:  2017-06-30       Impact factor: 2.967

4.  Foxp3 is correlated with VEGF-C expression and lymphangiogenesis in cervical cancer.

Authors:  Jiabu Tang; Zheng Yang; Zhuo Wang; Zhen Li; Hongmei Li; Jinbao Yin; Min Deng; Wei Zhu; Chao Zeng
Journal:  World J Surg Oncol       Date:  2017-09-18       Impact factor: 2.754

5.  FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer.

Authors:  Shucai Yang; Yi Liu; Ming-Yue Li; Calvin S H Ng; Sheng-Li Yang; Shanshan Wang; Chang Zou; Yujuan Dong; Jing Du; Xiang Long; Li-Zhong Liu; Innes Y P Wan; Tony Mok; Malcolm J Underwood; George G Chen
Journal:  Mol Cancer       Date:  2017-07-17       Impact factor: 27.401

6.  The effect of foxp3-overexpressing Treg cells on non-small cell lung cancer cells.

Authors:  Jiangzhou Peng; Zigang Yu; Lei Xue; Jiabin Wang; Jun Li; Degang Liu; Qiang Yang; Yihui Lin
Journal:  Mol Med Rep       Date:  2018-02-13       Impact factor: 2.952

Review 7.  Regulatory T Cell and Forkhead Box Protein 3 as Modulators of Immune Homeostasis.

Authors:  Leonn Mendes Soares Pereira; Samara Tatielle Monteiro Gomes; Ricardo Ishak; Antonio Carlos Rosário Vallinoto
Journal:  Front Immunol       Date:  2017-05-26       Impact factor: 7.561

8.  miRNA-218 regulates the proliferation and apoptosis of cervical cancer cells via targeting Gli3.

Authors:  Jing Zhang; Shengze Li; Yanhua Li; Hongli Liu; Yuan Zhang; Qingsong Zhang
Journal:  Exp Ther Med       Date:  2018-07-20       Impact factor: 2.447

9.  Long noncoding RNA UFC1 is activated by E2F1 and exerts oncogenic properties by functioning as a ceRNA of FOXP3.

Authors:  Jie Xi; Jing Feng; Saitian Zeng; Ping Huang
Journal:  Cancer Med       Date:  2018-05-23       Impact factor: 4.452

10.  The Expression of PD-L1 and B7-H4 in Thymic Epithelial Tumor and Its Relationship With Tumor Immune-Infiltrating Cells.

Authors:  Xiaotian Yan; Jie Feng; Bo Hong; Yun Qian
Journal:  Front Oncol       Date:  2021-07-08       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.